A carregar...
Publicação
Sycamore-walgreens fiel lab: aquisitions background, industry overview and precedent transaction analysis
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.1 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
In this study, we evaluate whether Sycamore Partners’ March 2025 offer for Walgreens Boots Alliance is fair relative to intrinsic value and to the value implied by a leveraged buyout. We estimate standalone value using discounted cash flow and market benchmarks, and build an APV based LBO model with deleveraging driven by free cash flow. Results indicate WBA traded below intrinsic value before the deal, heavy sector saturation, PBM reimbursement pressure, and weak primary care returns. Precedent transactions benchmarking supports
valuation ranges showing the offer is fair on a risk adjusted basis while leaving upside to the sponsor
Descrição
Palavras-chave
Walgreens boots alliance Leveraged buyout (LBO) Private equity Strategic turnaround Industry due diligence Precedent transactions valuation